March 24, 2026. 11 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score.
Scientists Identify Protein That Slows Key Effects of Aging – SciTechDaily
Article Summary This article discusses aging-related immune dysfunction and chronic inflammation, topics relevant to cannabis clinicians evaluating cannabinoid anti-inflammatory mechanisms in older populations.
Read more →Ohio Breweries Urge Legislative Override Vote on THC Beverage Bill | Brewbound.com
Ohio breweries are advocating for legislative action on THC beverage regulation, which may interest clinicians monitoring cannabis product standardization and regulatory developments.
Read more →5 Jersey City smoke shops closed for illegal cannabis, vape sales – NJBIZ
Jersey City authorities closed five smoke shops and issued 26 summonses for unlicensed operations and unauthorized cannabis sales, illustrating regulatory enforcement gaps relevant to understanding illicit market persistence.
Read more →The ‘Silent Killer of Cannabis Greenhouse Margins’
This article discusses harvest index efficiency in cannabis cultivation and COโ enrichment’s effects on biomass, topics relevant to clinicians interested in cultivation factors affecting final product quality and yield.
Read more →Oshkosh man arrested in Antigo on drug charges – WSAW
A man was arrested in Wisconsin with 29 grams of THC found in his vehicle, illustrating routine law enforcement cannabis seizures and possession charges.
Read more →US (CA): Solful to open fourth dispensary in Petaluma – MMJDaily
A California dispensary operator expands its retail footprint, representing ongoing commercial market development that clinicians may monitor for local patient access implications.
Read more →Leading Cannabis Brand Select Unveils Briq 2, the New Gold Standard for Smooth, Flavorful Vaping
Select cannabis brand announces Briq 2 vaporizer with proprietary flavor technology; may interest clinicians tracking cannabis delivery device innovation and consumer product features.
Read more →GOP Senator To File Bill Promoting Psychedelics Research And Treatment For Veterans
Summary A GOP senator plans to introduce legislation supporting psychedelics research and veteran treatment, representing broader legislative interest in alternative therapies that may intersect with cannabis policy discussions.
Read more →Cuba man pleads guilty to operating a marijuana grow operation – Department of Justice
A Cuba resident pleaded guilty to operating an illegal marijuana cultivation operation, representing law enforcement activity relevant to understanding cannabis supply chain regulation and legal consequences.
Read more →More than $1.2 million in marijuana products seized during truck inspection on I-80 – FOX56
State police seized over $1.2 million in marijuana products during a routine commercial vehicle inspection on Interstate 80, illustrating enforcement patterns in cannabis trafficking interdiction.
Read more →Anti-Aging Protein Research Takes a Step Forward with Cell Cloning – PR Newswire
Summary This article covers anti-aging protein research using cell cloning techniques. While not cannabis-specific, cannabinoid effects on cellular aging and longevity represent an emerging research area of potential clinical interest.
Read more →Digest-Level Clinical Commentary
These digest items reveal a field in transition across three distinct domains: the scientific foundation for cannabis therapeutics is advancing with aging-related research suggesting potential anti-inflammatory applications, regulatory frameworks remain fragmented and inconsistent (evidenced by enforcement actions alongside legislative efforts to expand legal access), and commercial operations continue to face compliance challenges that undermine the professionalization necessary for evidence-based clinical practice. For practitioners like myself, this fragmentation means patients deserve clear guidance about which cannabinoid formulations have genuine clinical support, while acknowledging that the gap between promising basic science and rigorous clinical trials in humans remains substantial and cannot yet justify broad claims about anti-aging or anti-inflammatory efficacy in routine practice.
These items reflect the fragmented regulatory landscape surrounding cannabis, with enforcement actions and legislative efforts occurring simultaneously across jurisdictions, while legitimate commercial interests seek clarity on product categories like THC beverages. The digest also captures ongoing scientific investigation into cannabis constituents and related compounds, suggesting clinicians may eventually have more evidence-based information to counsel patients, though significant research gaps remain. Meanwhile, illicit cultivation and distribution continue to represent substantial law enforcement activity, indicating that regulatory legitimacy has not fully displaced uncontrolled market operations.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
FAQ
This News item was assembled from structured source metadata and pipeline scoring.
Have thoughts on this? Share it: